ZEB2 is reported to be an oncogene in multiple malignancies, including liver cancer [35], breast cancer [36], colorectal cancer [37], esophageal squamous cell carcinoma [38], and NSCLC [39, 40]. This evidence concerns the gene ZEB2 and non-small cell lung carcinoma.